Corcept Completes Enrollment in Phase 4 CATALYST Trial
Go back to Corcept Completes Enrollment in Phase 4 CATALYST Trial| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 90.52 +0.80 (0.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.72 | 52 Week High | $10.00 | |||
| Open | $88.50 | 52 Week Low | $3.22 | |||
| Day High | $91.45 | P/E | N/A | |||
| Day Low | $87.22 | EPS | $-0.46 | |||
| Volume | 1,893,055 | |||||
